- Panacea Biotec enters collaboration with Bionpharma for generics worth $800 million
Share prices spiked upon the development, going as high as 9.75% (Rs 148 a piece) on the Bombay Stock Exchange before 11:00 am on Friday.
Panacea Biotec, US's Bionpharma join hands for 7 drugsUnder the collaboration, Panacea will be responsible for development, filing, registration, manufacturing and supply of these ANDAs, the co...
Bionpharma buys 25 products from specialty drug maker Banner Life SciencesThe combined revenue of the acquired products is estimated at more than $70 million and forms a mix of high-potency steroidal, antiviral, e...